Delivery Order SPE2DE21D0005-SPE2D624F98DF
Award Date 3/11/24
Potential Completion Date 3/15/24
Potential Value $1.1K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Canton, MA 02021, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
65
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $1,118.88 fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading manufacturer of regenerative medicine products. The order is for PURAPLY AM wound care dressings, which are advanced skin substitutes used to support tissue repair and regeneration. Organogenesis is an experienced federal contractor, holding several significant Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs (VA) and DLA...
- This is a $8,800.00 fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a manufacturer of regenerative medicine products. The contract is for the delivery of PURAPLY AM XT wound care dressings and has a completion date of June 25, 2024. Organogenesis Inc. is a leading provider of advanced wound care and surgical biologics to the federal government, particularly the Department of Defense (DoD) and Department of Veterans...
- This is a fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The $1,504.00 contract is for the supply of PURAPLY MICRONIZED, 500MG, a specialized medical product used for advanced wound care. The award has an ultimate completion date of July 21, 2025. Organogenesis is a for-profit manufacturer that holds several significant federal Indefinite Delivery Vehicles (IDVs)...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,118.88 fixed-price delivery order with economic price adjustment to Organogenesis Inc., a leading regenerative medicine company based in Canton, Massachusetts. The order is for PURAPLY AM (2x2) 4 SQ CM, an advanced wound care product. This order is part of Organogenesis' broader federal contract vehicles, including a $49.5 million multiple-award Indefinite Delivery Contract with DLA Troop Support Medical for wound care...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company. The contract, valued at $4,645.00, is for the supply of PURAPLY MZ 500MG, a regenerative wound care product. Organogenesis is a for-profit organization and a manufacturer of goods. The contract does not utilize any set-aside designations. This delivery order is part of a larger $49.5 million multiple-award Indefinite Delivery...
- This $8,500 fixed-price delivery order was awarded to Organogenesis Inc., a regenerative medicine company, by the Defense Logistics Agency (DLA) Troop Support Medical on September 11, 2024. The order is for the supply of PURAPLY AM XT, a wound care product, with an ultimate completion date of September 16, 2024. Organogenesis is a key supplier of advanced wound care and surgical biologics products to the U.S. government, primarily serving the Department of Defense and Department of Veterans...
- This is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company. The $8,800.00 contract is for the supply of PURAPLY AM XT wound care dressings. This order is part of a larger $183.15 million Multiple Award Indefinite Delivery Contract (IDC) issued by the DLA for medical and surgical supplies under the Medical/Surgical ECAT Program. Organogenesis also holds other significant IDVs with the...
- This is a $3,400 fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The contract is for the supply of PURAPLY AM XT EF, a 5-layer fenestrated wound dressing product, with an ultimate completion date of July 3, 2025. Organogenesis is an established federal contractor, holding several Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs (VA)...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $1,118.88 fixed-price delivery order to Organogenesis Inc. for PURAPLY AM (2X2) 4 SQ CM wound care dressing, with an ultimate completion date of September 29, 2025. The contract was awarded on September 23, 2025, without set-aside designation, allowing Organogenesis to compete as a standard commercial vendor. The place of performance is the company's headquarters in Canton, Massachusetts. PURAPLY AM is an advanced...
- The U.S. Department of Defense's Medical Supply Chain (Defense Logistics Agency Troop Support Medical) has awarded Organogenesis Inc. a $8,500.00 fixed-price delivery order contract (SPE2DE21D0005|SPE2D624F9CS2) for the supply of PURAPLY AM XT 4.91x4.91 medical products. This delivery order is part of Organogenesis' existing $49.5 million multiple-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency for wound care dressings, discs, and medical materials. Organogenesis is...
- SPE2DE21D0005Indefinite Delivery Contract
- SPE2DE21D0005-SPE2D624F98DFDelivery Order
This is a $1,118.88 fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company, to provide PURAPLY AM wound dressings. The order is part of a larger $49.5 million multiple-award indefinite delivery contract (IDC) that Organogenesis holds with DLA for wound care dressings, discs, and other medical materials through May 2026. Organogenesis also maintains Blanket Purchase Agreements valued up to $7 million with the Department of Veterans Affairs (VA) to supply advanced wound care solutions and surgical biologics. This delivery order does not utilize a set-aside designation.
Generated 6/10/24, 9:27 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 3/11/24 |